Urgent call for better use of existing vaccines and development of new vaccines to tackle AMR
WHO today released the first-ever report on the pipeline of the vaccines currently in development to prevent infections caused by antimicrobial-resistant (AMR) bacterial pathogens. WHO’s analysis points to the need to accelerate trials for AMR related vaccines in late-stage development and maximise the use of existing vaccines. The silent pandemic of antimicrobial resistance is of major growing public health concern.…
Read More
